1. Home
  2. INSE vs TNXP Comparison

INSE vs TNXP Comparison

Compare INSE & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INSE

Inspired Entertainment Inc.

HOLD

Current Price

$8.18

Market Cap

206.2M

Sector

Technology

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$11.46

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSE
TNXP
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.2M
198.6M
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
INSE
TNXP
Price
$8.18
$11.46
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
91.2K
441.7K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
$199,800,000.00
$13,107,000.00
Revenue This Year
N/A
$558.11
Revenue Next Year
$4.26
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
30.25
29.85
52 Week Low
$6.11
$10.87
52 Week High
$9.95
$69.65

Technical Indicators

Market Signals
Indicator
INSE
TNXP
Relative Strength Index (RSI) 62.74 42.21
Support Level $7.91 N/A
Resistance Level $8.36 $14.85
Average True Range (ATR) 0.40 0.84
MACD 0.05 -0.16
Stochastic Oscillator 97.82 19.82

Price Performance

Historical Comparison
INSE
TNXP

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: